{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1380292619624671234.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"Frederick R. Appelbaum"}],"foaf:familyName":[{"@value":"Appelbaum"}],"foaf:givenName":[{"@value":"Frederick R."}]}],"career":[{"institution":{"notation":[{"@value":"From the Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; the Department of Medicine, University of Washington, Seattle; and the Department of Pathology, University of New Mexico and UNM Cancer Center, Albuquerque."}]}}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1360292619624671232","@type":"Article","productIdentifier":[{"@type":"DOI","@value":"10.1182/blood-2002-07-2283"},{"@type":"URI","@value":"http://ashpublications.org/blood/article-pdf/101/9/3628/1257066/h80903003628.pdf"}],"notation":[{"@value":"Cholesterol-modulating agents kill acute myeloid leukemia cells and sensitize them to therapeutics by blocking adaptive cholesterol responses"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1182/blood-2002-07-2283_MT9VECJ2i524rFGCMyraQMqhRrz"}]}